Controllable release of salmon-calcitonin in injectable calcium phosphate cement modified by chitosan oligosaccharide and collagen polypeptide

被引:28
作者
Li, D. X.
Fan, H. S. [1 ]
Zhu, X. D.
Tan, Y. F.
Xiao, W. Q.
Lu, J.
Xiao, Y. M.
Chen, J. Y.
Zhang, X. D.
机构
[1] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu, Peoples R China
[2] Sichuan Inst Chinese Materia Medica, Chengdu, Peoples R China
关键词
D O I
10.1007/s10856-007-3084-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of this research is to study the effect of the controlled releasing character of the salmon calcitonin (S-CT) loaded injectable calcium phosphate cement (CPC) modified by adding organic phase, chitosan oligosaccharide (CO) and collagen polypeptide (CP). The uniform design was used to determine the basic formulation with suitable injectable time for clinical application, and then the changes of the physical characters, the controlled releasing character of the modified CPC along with the ratio of the organic phase were also evaluated in vitro. The surface morphous of the modified CPC been implanted in the abdominal cavity or soaked into the serum of rat was also observed by scanning electron microscope (SEM). The result shows that a suitable formulation of modified CPC could be got, and the injectable time is 12 min, the compressive strength is 12 MPa, and the final setting time is 40 min. Comparing with the CPC without organic phase, the releasing rate of S-CT would increase along with the increase of the organic phase after 7th day. Therefore, a novel S-CT loaded bioactive injectable CPC for treating osteoporosis induced bone defect was obtained, and the release of the containing S-CT was controlled easily through adjusting the ratio of CO and CP.
引用
收藏
页码:2225 / 2231
页数:7
相关论文
共 30 条
[1]   Evaluation of an injectable calcium phosphate cement as an autograft substitute for transpedicular lumbar interbody fusion: a controlled, prospective study in the sheep model [J].
Blattert, TR ;
Delling, G ;
Weckbach, A .
EUROPEAN SPINE JOURNAL, 2003, 12 (02) :216-223
[2]   Fighting osteoporosis on two fronts [J].
Burckhardt, P .
BONE, 2006, 38 (02) :1-1
[3]   Injectable calcium phosphate cement as a filler for bone defects around oral implants: an experimental study in goats [J].
Comuzzi, L ;
Ooms, E ;
Jansen, JA .
CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (03) :304-311
[4]   Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4) [J].
Drissi, H ;
Lieberherr, M ;
Hott, M ;
Marie, PJ ;
Lasmoles, F .
CYTOKINE, 1999, 11 (03) :200-207
[5]  
Fang Kai-tai, 1980, Acta Mathematicae Applacatae Sinica, V3, P363
[6]   CALCITONIN HAS DIRECT EFFECTS ON 3[H]-THYMIDINE INCORPORATION AND ALKALINE-PHOSPHATASE ACTIVITY IN HUMAN OSTEOBLAST-LINE CELLS [J].
FARLEY, JR ;
WERGEDAL, JE ;
HALL, SL ;
HERRING, S ;
TARBAUX, NM .
CALCIFIED TISSUE INTERNATIONAL, 1991, 48 (05) :297-301
[7]   Noninvasive bone replacement with a new injectable calcium phosphate biomaterial [J].
Gauthier, O ;
Khairoun, I ;
Bosco, J ;
Obadia, L ;
Bourges, X ;
Rau, C ;
Magne, D ;
Bouler, JM ;
Aguado, E ;
Daculsi, G ;
Weiss, P .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (01) :47-54
[8]   Calcium phosphate cements as bone drug delivery systems: A review [J].
Ginebra, M. P. ;
Traykova, T. ;
Planell, J. A. .
JOURNAL OF CONTROLLED RELEASE, 2006, 113 (02) :102-110
[9]   An injectable calcium phosphate cement as a bone-graft substitute in the treatment of displaced lateral tibial plateau fractures [J].
Horstmann, WG ;
Verheyen, CCPM ;
Leemans, R .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2003, 34 (02) :141-144
[10]  
HWANG JJH, 1986, J DENT RES, V65, P195